SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study.

Gil, H-I; Zo, S; Jones, PW; Kim, B-G; Kang, N; Choi, Y; Cho, HK; Kang, D; Cho, J; Park, HY; et al. Gil, H-I; Zo, S; Jones, PW; Kim, B-G; Kang, N; Choi, Y; Cho, HK; Kang, D; Cho, J; Park, HY; Shin, SH (2021) Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis, 16. pp. 1509-1517. ISSN 1178-2005 https://doi.org/10.2147/COPD.S297089
SGUL Authors: Jones, Paul Wyatt

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (579kB) | Preview

Abstract

Purpose: The chronic obstructive pulmonary disease (COPD) assessment test (CAT) is widely used to assess the impact of COPD symptoms on health status. Whilst the CAT consists of eight different items, details on the distribution of each item are limited. This study aimed to investigate the distribution and clinical implication of each CAT item, stratified by CAT severity group, in stable COPD patients. Patients and Methods: This was a cross-sectional study at a single referral hospital in South Korea. Spirometry confirmed COPD patients with CAT measured at the first clinical visit were retrospectively identified. Patients were categorized into three groups: low (0 ≤ CAT < 10), medium (10 ≤ CAT < 20), and high (20 ≤ CAT ≤ 40) impact group. For the purpose of this analysis, the first four items (cough, sputum, chest tightness, and dyspnea) and the remaining four items (activities, confidence, sleep and energy) were also grouped as "pulmonary" and "extra-pulmonary", respectively. Results: A total of 815 patients were included, and mean (SD) forced expiratory volume in 1 s (FEV1) was 62.8 (17.4) % pred. Among them, 300 patients (36.8%) were in the high impact group and had a greater exacerbation history and lower lung function. The proportion of "extra-pulmonary" items score was greater in patients with higher total CAT scores, with the activity and confidence items showing higher scores. Conclusion: In our study, in addition to dyspnea, activity limitation is a particular problem in individual patients with higher CAT total scores, for which physicians need to pay more attention. Our study suggests that whilst CAT total score captures the overall impact of COPD, each item of the CAT contains potentially useful information in understanding the patient's symptom burden.

Item Type: Article
Additional Information: © 2021 Gil et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Keywords: COPD, COPD assessment test, patient reported outcome, symptom, COPD, COPD assessment test, patient reported outcome, symptom, 1102 Cardiorespiratory Medicine and Haematology, Respiratory System
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Int J Chron Obstruct Pulmon Dis
ISSN: 1178-2005
Language: eng
Dates:
DateEvent
1 June 2021Published
4 May 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 3.0
Projects:
Project IDFunderFunder ID
2016ER670100Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2016ER670101Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2016ER670102Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2018ER67100Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2018ER67101Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2018ER67102Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
2021ER120500Korea National Institute of Healthhttp://dx.doi.org/10.13039/501100003653
PubMed ID: 34103908
Web of Science ID: WOS:000656588300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113352
Publisher's version: https://doi.org/10.2147/COPD.S297089

Actions (login required)

Edit Item Edit Item